RE:RE:expiration of optionsYet another end-of- day support.
I have lost count. First there were enough, that I noticed & made note of it on here.
so far, since my first notice 3/3 end of day supports.
there were ample before thst. Just can't give an exact number.
My original notice was in response to " no share activity indicating a buyout or partership"
My point, then & now?
back pre A.N. Deal the price activity was almost identical to now.
Very low volume. Near bottom low pricing, Yet, constant end of day support.
Coincidence?
well wre are at least 6/6 trading days.
S.P. In general?
right now, considering the upside prospects, silly low right now.
The expected updates will be great catalyst to move the price.
end game, a total buyout.
significantly higher than any prices we have seen in many months.
ironically the traders will come & go throughout that rise.
being the case with a decent partnership, license agreement.
A total buyout, Asside from shareholders vote, little would change from the offered price.
one scinario would be competitive bids.
First step, FDA report.
hypothetically it is possible , mutiple deals are in negotiations. With final details being blank, pending the FDA trial parameters.
Using an anlgy?
people can put in a conditional offer on a house , pending a formal inspection report.
being dates, price etc.
None of that information would be public.
After the report, based on findings, there may be minor adjustments to the price.
only once all details are signed off does the deal become public.
Same story. Could ( might) be going on with Onc.
The FDA report will be the first step. The additional steps could be not far after.
Those forgetting, or not knowing.
Onc approached FDA for a meeting to discuss MBc inclusion details.
ONCs web site says Gobblet & specifically MBc involves Roche & CGAR.
The MBc says TBD.
enjoy the rest iof the night.